The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kirson Eilon D. since 2016.
The trader's CIK number is 1654356.
At the time of the last reporting, Kirson Eilon D. was the Chief Scientific Officer of Novocure Ltd. (stock ticker symbol NVCR).
Also see all insider trading activities at Novocure Ltd.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | NVCR | 0 | $0 | 168,813 | $7,624,788 | 284,958 | $8,622,328 |
| 2018 | NVCR | 0 | $0 | 519,306 | $14,486,283 | 598,637 | $4,673,689 |
| 2017 | NVCR | 0 | $0 | 146,130 | $2,555,028 | 0 | $0 |
| 2016 | NVCR | 0 | $0 | 0 | $0 | 341,711 | $58,090 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-02-27 | NVCR | Option Ex | 6,945 | 52.90 | 367,390 |
| 2019-02-22 | NVCR | Option Ex | 36,400 | 53.38 | 1,943,032 |
| 2019-02-22 | NVCR | Option Ex | 36,400 | 53.38 | 1,943,032 |
| 2019-02-22 | NVCR | Option Ex | 36,400 | 53.38 | 1,943,032 |
| 2019-01-17 | NVCR | Sale | 68,813 | 45.25 | 3,113,788 |
| 2019-01-16 | NVCR | Sale | 100,000 | 45.11 | 4,511,000 |
| 2019-01-17 | NVCR | Option Ex | 68,813 | 14.37 | 988,842 |
| 2019-01-16 | NVCR | Option Ex | 100,000 | 14.37 | 1,437,000 |
| 2018-06-13 | NVCR | Option Ex | 68,250 | 12.91 | 881,448 |
| 2018-06-04 | NVCR | Option Ex | 346,161 | 7.22 | 2,499,282 |
| 2018-06-04 | NVCR | Sale | 346,161 | 29.99 | 10,381,368 |
| 2018-04-18 | NVCR | Sale | 147,825 | 24.00 | 3,547,800 |
| 2018-04-18 | NVCR | Option Ex | 147,825 | 3.44 | 508,518 |
| 2018-02-22 | NVCR | Option Ex | 36,401 | 21.55 | 784,441 |
| 2018-01-11 | NVCR | Sale | 25,320 | 22.00 | 557,115 |
| 2017-11-06 | NVCR | Sale | 9,100 | 22.00 | 200,200 |
| 2017-11-02 | NVCR | Sale | 300 | 22.00 | 6,600 |
| 2017-11-03 | NVCR | Sale | 3,100 | 22.00 | 68,200 |
| 2017-11-01 | NVCR | Sale | 22,119 | 22.01 | 486,817 |
| 2017-10-31 | NVCR | Sale | 150 | 22.00 | 3,300 |
| 2017-06-21 | NVCR | Sale | 66,361 | 16.77 | 1,113,205 |
| 2017-06-19 | NVCR | Sale | 15,000 | 15.06 | 225,885 |
| 2017-06-13 | NVCR | Sale | 9,044 | 15.01 | 135,768 |
| 2017-06-09 | NVCR | Sale | 15,000 | 15.02 | 225,225 |
| 2017-06-12 | NVCR | Sale | 5,956 | 15.08 | 89,828 |
| 2016-12-05 | NVCR | Option Ex | 156,073 | .17 | 26,532 |
| 2016-12-05 | NVCR | Option Ex | 156,073 | .17 | 26,532 |
| 2016-04-18 | NVCR | Option Ex | 29,565 | .17 | 5,026 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kirson Eilon D. (Chief Scientific Officer of Novocure Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.